If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.95    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (29.412%)
Market Cap: £320.00k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Director Appointment

20 Feb 2023 07:49

RNS Number : 4155Q
Iconic Labs PLC
20 February 2023
 

20 February 2023

 

Iconic Labs PLC

("Iconic" or the "Company")

Director Appointment

 

Iconic Labs PLC (LSE:ICON), is pleased to announce that Emmanuel Blouin has been appointed to the Board of Directors with immediate effect.

Mr. Blouin has 25 years of investment and banking experience. He was a senior banker with Morgan Stanley, JP Morgan and BNP Paribas, during which he was involved in over €50 billion of capital markets, corporate finance and property transactions across Europe. In 2008, Mr. Blouin established Esterel Capital, a London-based boutique focusing on real estate and finance, where he continues to be Managing Partner.

Mr. Blouin is also currently a director of Courbet SA, a hospitality investment company listed on the Paris Stock Exchange, as well as an Independent Non-Executive Director of Aradei Capital, a commercial property investment and management company listed on the Casablanca Stock Exchange.

The following information is disclosed about Mr. Emmanuel Blouin:

Current Directorships / Partnerships

Aradei Capital

Courbet SA

Esterel Capital LLP

Stanrock Capital Ltd

Squareconcept Property Management Ltd

Previous Directorships / Partnerships held in the past 5 years: None

Brad Taylor, CEO of Iconic Labs, commented:

"I welcome Emmanuel to the Iconic board of directors. He is a highly skilled professional with significant expertise in corporate finance and international dealmaking. This experience, coupled with his vast network, will serve Iconic and its shareholders well as the company develops and implements an acquisition and growth strategy. With Iconic directors now in the United States, United Kingdom, and Europe, we are well-positioned to maximize our potential for value creation."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

- ENDS -

 

For any further information or enquiries please contact:

 

ir@iconiclabs.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBLBLXLLZBBK
Date   Source Headline
28th Feb 20232:05 pmRNSSecond Price Monitoring Extn
28th Feb 20232:00 pmRNSPrice Monitoring Extension
28th Feb 20237:57 amRNSChange of Registered Office
28th Feb 20237:56 amRNSTotal Voting Rights
24th Feb 20234:35 pmRNSPrice Monitoring Extension
22nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20239:05 amRNSSecond Price Monitoring Extn
22nd Feb 20239:00 amRNSPrice Monitoring Extension
21st Feb 20234:40 pmRNSSecond Price Monitoring Extn
21st Feb 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20232:05 pmRNSSecond Price Monitoring Extn
21st Feb 20232:00 pmRNSPrice Monitoring Extension
20th Feb 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20237:49 amRNSDirector Appointment
16th Feb 20239:05 amRNSSecond Price Monitoring Extn
16th Feb 20239:00 amRNSPrice Monitoring Extension
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR1 notification
10th Feb 20232:05 pmRNSSecond Price Monitoring Extn
10th Feb 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
10th Feb 20237:00 amRNSSubscription of Convertible Notes
9th Feb 20232:00 pmRNSPrice Monitoring Extension
9th Feb 20231:04 pmRNSConversion of Securities
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20232:05 pmRNSSecond Price Monitoring Extn
8th Feb 20232:00 pmRNSPrice Monitoring Extension
6th Feb 20237:18 amRNSConversion of Notes
2nd Feb 20237:55 amRNSRestructuring Update
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20238:52 amRNSTotal Voting Rights
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20238:04 amRNSConversion of Securities & Resignation of Director
27th Jan 202311:05 amRNSSecond Price Monitoring Extn
27th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 202312:08 pmRNSRestoration of Trading
25th Jan 20239:00 amRNSPrice Monitoring Extension
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.